Sunshine Biopharma Inc. (SBFMW) Operating income 2016–2025
Sunshine Biopharma Inc. (SBFMW) annual operating income history from SEC filings — each fiscal year as reported.
-$6.2MFY2025 · since FY2016: -$993,108 → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | -7.1% |
| FY2024 | -$5.8M | -21.5% |
| FY2023 | -$4.8M | +82.3% |
| FY2022 | -$27.0M | -1006.5% |
| FY2021 | -$2.4M | -323.0% |
| FY2020 | -$576,874 | +10.1% |
| FY2019 | -$641,636 | +44.9% |
| FY2018 | -$1.2M | -35.8% |
| FY2017 | -$857,190 | +13.7% |
| FY2016 | -$993,108 | — |
Source: SEC XBRL filings · For reference only · Not investment advice